Alisha Moore

801 total citations
17 papers, 84 citations indexed

About

Alisha Moore is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Alisha Moore has authored 17 papers receiving a total of 84 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 9 papers in Radiation and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Alisha Moore's work include Advanced Radiotherapy Techniques (9 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Head and Neck Cancer Studies (3 papers). Alisha Moore is often cited by papers focused on Advanced Radiotherapy Techniques (9 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Head and Neck Cancer Studies (3 papers). Alisha Moore collaborates with scholars based in Australia, United Kingdom and United States. Alisha Moore's co-authors include Nicholas Hardcastle, Danny Rischin, Hisham Mehanna, Tomas Kron, Min Yao, Shankar Siva, Sandro Porceddu, John Waldron, Quynh‐Thu Le and Vincent Grégoire and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Alisha Moore

16 papers receiving 83 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alisha Moore Australia 6 39 31 29 22 14 17 84
M Thompson United Kingdom 3 26 0.7× 26 0.8× 27 0.9× 46 2.1× 6 0.4× 9 111
Silvia Foti Italy 4 52 1.3× 81 2.6× 13 0.4× 32 1.5× 9 0.6× 25 135
Jacqueline Lam Canada 5 82 2.1× 15 0.5× 17 0.6× 33 1.5× 12 0.9× 9 126
Sameera Kumar United States 8 91 2.3× 55 1.8× 40 1.4× 53 2.4× 7 0.5× 18 155
Adrian Wai Chan Canada 5 14 0.4× 18 0.6× 9 0.3× 50 2.3× 25 1.8× 26 84
Joycelin Canavan United States 3 13 0.3× 27 0.9× 18 0.6× 15 0.7× 19 1.4× 5 64
K. Geropantas United Kingdom 6 23 0.6× 32 1.0× 16 0.6× 20 0.9× 23 1.6× 11 99
Warren Grant United Kingdom 7 25 0.6× 28 0.9× 44 1.5× 39 1.8× 4 0.3× 11 92
Ralph Gourlay Australia 4 58 1.5× 66 2.1× 23 0.8× 36 1.6× 11 0.8× 4 123
A. Mazal France 8 32 0.8× 26 0.8× 17 0.6× 72 3.3× 19 1.4× 11 174

Countries citing papers authored by Alisha Moore

Since Specialization
Citations

This map shows the geographic impact of Alisha Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alisha Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alisha Moore more than expected).

Fields of papers citing papers by Alisha Moore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alisha Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alisha Moore. The network helps show where Alisha Moore may publish in the future.

Co-authorship network of co-authors of Alisha Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Alisha Moore. A scholar is included among the top collaborators of Alisha Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alisha Moore. Alisha Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Martin, Jarad, et al.. (2025). Implementation of Knowledge-Based Planning as a Quality Assurance Feedback Tool for a Multicentre Prostate Clinical Trial (TROG 18.01 NINJA). International Journal of Radiation Oncology*Biology*Physics. 123(1). S200–S201.
3.
Hardcastle, Nicholas, Price Jackson, Lachlan McIntosh, et al.. (2024). Dose-Effect Relationship of Kidney Function After SABR for Primary Renal Cell Carcinoma: TROG 15.03 FASTRACK II. International Journal of Radiation Oncology*Biology*Physics. 120(3). 648–654. 5 indexed citations
4.
Taylor, Paige A., Elizabeth Miles, Lone Hoffmann, et al.. (2023). Prioritizing clinical trial quality assurance for photons and protons: A failure modes and effects analysis (FMEA) comparison. Radiotherapy and Oncology. 182. 109494–109494. 5 indexed citations
5.
Kron, Tomas, Alan Herschtal, Nicholas Hardcastle, et al.. (2023). Comparison of Changes in Pulmonary Function After Stereotactic Body Radiation Therapy Versus Conventional 3-Dimensional Conformal Radiation Therapy for Stage I and IIA Non-Small Cell Lung Cancer: An Analysis of the TROG 09.02 (CHISEL) Phase 3 Trial. International Journal of Radiation Oncology*Biology*Physics. 117(2). 378–386. 4 indexed citations
6.
Hardcastle, Nicholas, Mathias Bressel, Alisha Moore, et al.. (2023). Impact on Pulmonary Function in a Randomized Trial of Single-Fraction and Multifraction Stereotactic Body Radiation Therapy for Pulmonary Oligometastatic Disease: An Analysis of TROG 13.01 (SAFRON II). International Journal of Radiation Oncology*Biology*Physics. 118(4). 944–951. 1 indexed citations
7.
Greer, Peter B., et al.. (2022). Remote EPID-based dosimetric auditing using DVH patient dose analysis. Physics in Medicine and Biology. 68(3). 35018–35018. 1 indexed citations
8.
Chang, David, Alisha Moore, Sylvia van Dyk, & Pearly Khaw. (2022). Why quality assurance is necessary in gynecologic radiation oncology. International Journal of Gynecological Cancer. 32(3). 402–406. 2 indexed citations
9.
Khaw, Pearly, Viet Do, Karen Lim, et al.. (2021). Radiotherapy Quality Assurance in the PORTEC-3 (TROG 08.04) Trial. Clinical Oncology. 34(3). 198–204. 2 indexed citations
11.
Hardcastle, Nicholas, Xenia Ray, Alisha Moore, et al.. (2021). Personalising treatment plan quality review with knowledge-based planning in the TROG 15.03 trial for stereotactic ablative body radiotherapy in primary kidney cancer. Radiation Oncology. 16(1). 142–142. 10 indexed citations
13.
Moore, Alisha, David J. Willis, Mohamed Akra, et al.. (2021). The Feasibility of Quality Assurance in the TOPGEAR International Phase III Clinical Trial of Neoadjuvant Chemoradiotherapy for Gastric Cancer (An Intergroup Trial of the AGITG/TROG/EORTC/CCTG). International Journal of Radiation Oncology*Biology*Physics. 111(3). S38–S39. 2 indexed citations
14.
Porceddu, Sandro, Sue S. Yom, Howard Liu, et al.. (2020). Head and Neck Cancer International Group (HNCIG) Consensus Guidelines for the Delivery of Postoperative Radiation Therapy in Complex Cutaneous Squamous Cell Carcinoma of the Head and Neck (cSCCHN). International Journal of Radiation Oncology*Biology*Physics. 107(4). 641–651. 25 indexed citations
15.
Colyvas, Kim, et al.. (2018). A remote EPID-based dosimetric TPS-planned audit of centers for clinical trials: outcomes and analysis of contributing factors. Radiation Oncology. 13(1). 178–178. 5 indexed citations
16.
Moore, Alisha. (2018). Observer variation in the delineation of organs at risk for head and neck radiation therapy treatment planning: a systematic review protocol. The JBI Database of Systematic Reviews and Implementation Reports. 16(1). 50–56. 2 indexed citations
17.
Cigler, Tessa, Pamela Klein, SA Hurvitz, et al.. (2017). Abstract P5-11-17: Body image in women with breast cancer using a scalp cooling system to reduce chemotherapy induced alopecia. Cancer Research. 77(4_Supplement). P5–11. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026